Modeling Hypertrophic IP3 Transients in the Cardiac Myocyte

Overview

Journal Biophys J

Publisher Cell Press

Specialty Biophysics

Date 2007 Aug 19

PMID 17693463

Citations 19

Authors

Michael Cooling

Peter Hunter

Edmund J Crampin

Affiliations

Soon will be listed here.

Abstract

Cardiac hypertrophy is a known risk factor for heart disease, and at the cellular level is caused by a complex interaction of signal transduction pathways. The IP3-calcineurin pathway plays an important role in stimulating the transcription factor NFAT which binds to DNA cooperatively with other hypertrophic transcription factors. Using available kinetic data, we construct a mathematical model of the IP3 signal production system after stimulation by a hypertrophic alpha-adrenergic agonist (endothelin-1) in the mouse atrial cardiac myocyte. We use a global sensitivity analysis to identify key controlling parameters with respect to the resultant IP3 transient, including the phosphorylation of cell-membrane receptors, the ligand strength and binding kinetics to precoupled (with G(alpha)GDP) receptor, and the kinetics associated with precoupling the receptors. We show that the kinetics associated with the receptor system contribute to the behavior of the system to a great extent, with precoupled receptors driving the response to extracellular ligand. Finally, by reparameterizing for a second hypertrophic alpha-adrenergic agonist, angiotensin-II, we show that differences in key receptor kinetic and membrane density parameters are sufficient to explain different observed IP3 transients in essentially the same pathway.

Citing Articles

Modeling the Interplay of Sex Hormones in Cardiac Hypertrophic Signaling.

Lakshmikanthan A, Kay M, Oomen P bioRxiv. 2025; .

PMID: 40060665 PMC: 11888296. DOI: 10.1101/2025.02.24.639810.

The Microenvironment of the Pathogenesis of Cardiac Hypertrophy.

Bazgir F, Nau J, Nakhaei-Rad S, Amin E, Wolf M, Saucerman J Cells. 2023; 12(13).

PMID: 37443814 PMC: 10341218. DOI: 10.3390/cells12131780.

Mechanisms underlying divergent relationships between Ca and YAP/TAZ signalling.

Khalilimeybodi A, Fraley S, Rangamani P J Physiol. 2022; 601(3):483-515.

PMID: 36463416 PMC: 10986318. DOI: 10.1113/JP283966.

Three dimensional coupled reaction-diffusion modeling of calcium and inositol 1,4,5-trisphosphate dynamics in cardiomyocytes.

Singh N, Adlakha N RSC Adv. 2022; 9(72):42459-42469.

PMID: 35542883 PMC: 9076935. DOI: 10.1039/c9ra06929a.

Systems modeling predicts that mitochondria ER contact sites regulate the postsynaptic energy landscape.

Leung A, Ohadi D, Pekkurnaz G, Rangamani P NPJ Syst Biol Appl. 2021; 7(1):26.

PMID: 34078916 PMC: 8172538. DOI: 10.1038/s41540-021-00185-7.

References

Bremnes T, Paasche J, Mehlum A, Sandberg C, Bremnes B, Attramadal H . Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem. 2000; 275(23):17596-604. DOI: 10.1074/jbc.M000142200. View

Mehta P, Griendling K . Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2006; 292(1):C82-97. DOI: 10.1152/ajpcell.00287.2006. View

Leinwand L . Calcineurin inhibition and cardiac hypertrophy: a matter of balance. Proc Natl Acad Sci U S A. 2001; 98(6):2947-9. PMC: 33335. DOI: 10.1073/pnas.051033698. View

Innamorati G, Le Gouill C, Balamotis M, Birnbaumer M . The long and the short cycle. Alternative intracellular routes for trafficking of G-protein-coupled receptors. J Biol Chem. 2001; 276(16):13096-103. DOI: 10.1074/jbc.M009780200. View

Kakita T, Hasegawa K, Adachi S, Morimoto T, Wada H, Kawamura T . Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res. 2001; 88(12):1239-46. DOI: 10.1161/hh1201.091794. View

Crabtree G, Olson E . NFAT signaling: choreographing the social lives of cells. Cell. 2002; 109 Suppl:S67-79. DOI: 10.1016/s0092-8674(02)00699-2. View

Wilkins B, Molkentin J . Calcineurin and cardiac hypertrophy: where have we been? Where are we going?. J Physiol. 2002; 541(Pt 1):1-8. PMC: 2290305. DOI: 10.1113/jphysiol.2002.017129. View

Hardt S, Sadoshima J . Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ Res. 2002; 90(10):1055-63. DOI: 10.1161/01.res.0000018952.70505.f1. View

Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F . Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2002; 22(1):131-9. PMC: 140062. DOI: 10.1093/emboj/cdg013. View

10.

Sivakumaran S, Hariharaputran S, Mishra J, Bhalla U . The Database of Quantitative Cellular Signaling: management and analysis of chemical kinetic models of signaling networks. Bioinformatics. 2003; 19(3):408-15. DOI: 10.1093/bioinformatics/btf860. View

11.

Xu C, Watras J, Loew L . Kinetic analysis of receptor-activated phosphoinositide turnover. J Cell Biol. 2003; 161(4):779-91. PMC: 2199375. DOI: 10.1083/jcb.200301070. View

12.

Kohno M, Pouyssegur J . Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. Prog Cell Cycle Res. 2003; 5:219-24. View

13.

Bai H, Wu L, Xing D, Liu J, Zhao Y . Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor. Chin Med J (Engl). 2004; 117(1):88-93. View

14.

Hunton D, Zou L, Pang Y, Marchase R . Adult rat cardiomyocytes exhibit capacitative calcium entry. Am J Physiol Heart Circ Physiol. 2003; 286(3):H1124-32. DOI: 10.1152/ajpheart.00162.2003. View

15.

Crampin E, Halstead M, Hunter P, Nielsen P, Noble D, Smith N . Computational physiology and the Physiome Project. Exp Physiol. 2004; 89(1):1-26. DOI: 10.1113/expphysiol.2003.026740. View

16.

Lloyd C, Halstead M, Nielsen P . CellML: its future, present and past. Prog Biophys Mol Biol. 2004; 85(2-3):433-50. DOI: 10.1016/j.pbiomolbio.2004.01.004. View

17.

Wilkins B, Molkentin J . Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun. 2004; 322(4):1178-91. DOI: 10.1016/j.bbrc.2004.07.121. View

18.

Lukas T . A signal transduction pathway model prototype I: From agonist to cellular endpoint. Biophys J. 2004; 87(3):1406-16. PMC: 1304549. DOI: 10.1529/biophysj.103.035253. View

19.

Taylor S, Chae H, Rhee S, EXTON J . Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature. 1991; 350(6318):516-8. DOI: 10.1038/350516a0. View

20.

Abdellatif M, Neubauer C, Lederer W, Rogers T . Angiotensin-induced desensitization of the phosphoinositide pathway in cardiac cells occurs at the level of the receptor. Circ Res. 1991; 69(3):800-9. DOI: 10.1161/01.res.69.3.800. View